Gilder Gagnon Howe & Co’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
Gilder Gagnon Howe & Co's TLSI Position: Q3 2026 in Review
Gilder Gagnon Howe & Co reduced its TriSalus Life Sciences (TLSI) stake by 3.7% in Q3 2026, selling an estimated $148K and leaving 818,936 shares worth $3.53M. The position accounts for 0.04% of the portfolio, ranked #183.
Gilder Gagnon Howe & Co first reported a position in TLSI in Q3 2021 and has held it in 13 quarters since. The position peaked at $8.35M in Q1 2022. 82 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.
- Gilder Gagnon Howe & Co held 818,936 shares of TriSalus Life Sciences worth $3.53M as of Q3 2026.
- Gilder Gagnon Howe & Co sold 31,145 TriSalus Life Sciences shares in Q3 2026, an estimated $148K.
- TriSalus Life Sciences made up 0.04% of Gilder Gagnon Howe & Co's portfolio in Q3 2026, its #183 holding.
- Gilder Gagnon Howe & Co first reported a position in TriSalus Life Sciences in Q3 2021 and has held it in 13 quarters since.
- Gilder Gagnon Howe & Co's TriSalus Life Sciences position peaked at $8.35M in Q1 2022.
- 82 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.
Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2026, filed 16 Nov 2026.